Production (Stage)
aTyr Pharma, Inc.
ATYR
$3.75
-$0.05-1.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.88M | -14.97M | -17.26M | -16.31M | -15.49M |
| Total Depreciation and Amortization | 383.00K | -1.00K | 388.00K | 383.00K | 770.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 654.00K | 216.00K | 141.00K | -8.00K | -67.00K |
| Change in Net Operating Assets | -1.58M | 1.62M | 3.57M | -4.52M | -7.59M |
| Cash from Operations | -15.42M | -13.13M | -13.16M | -20.45M | -22.38M |
| Capital Expenditure | -- | -25.00K | -15.00K | -8.00K | -17.00K |
| Sale of Property, Plant, and Equipment | -- | 7.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.42M | -6.07M | 17.96M | 6.74M | -1.34M |
| Cash from Investing | -4.42M | -6.09M | 17.95M | 6.73M | -1.36M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -131.00K | -128.00K | -125.00K | -123.00K | -121.00K |
| Issuance of Common Stock | 18.76M | 18.97M | 20.00K | 13.52M | 7.85M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 18.63M | 18.84M | -105.00K | 13.40M | 7.73M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.21M | -378.00K | 4.68M | -321.00K | -16.01M |